No title
BACKGROUND: Radioiodine (131I) has been used in thyroid cancer treatments for many years, and has demonstrated good results with regards to disease management. Radioiodine therapy is however partially empirical, as not very much is known concerning radiation dosimetry. At Skåne University Hospital, the number of treatments has been growing steadily over the past couple of years, resulting in an in
